New Partnership Between Generis And Risetime Provides Easy and Compliant Information Management for Cosmetics Industry
"We are absolutely thrilled about the incredible opportunities that this partnership brings to the table!" comments Patrick Windsor, Managing Director of Risetime. "By harnessing Risetime's exceptional expertise in FDA regulation and seamlessly integrating it with the cutting-edge CARA Platform, we're setting the stage for an extraordinary level of support to the Cosmetic and Beauty industries, ensuring their complete compliance with MoCRA regulations like never before!"
The key focus of this partnership will be the configuration of the CARA Platform for the Cosmetic and Beauty industries and support of the current MoCRA FDA regulations. As a data and content management platform, CARA helps companies in regulated industries such as finance, energy, and manufacturing transform their complex business processes and remain compliant. The unified CARA Life Sciences Platform™ is the pre-configured, out-of-the-box layer with standardised apps for Regulatory, Quality, Safety, and Clinical processes, powered by a single structured data lake that gives users instant access to cross-functional data and enables powerful process optimisation for pharmaceutical companies. This partnership will allow Generis to further expand and fine-tune their offering for the Cosmetics industry.
"Our partnership with Risetime is a very exciting opportunity."
Risetime is a Chicago-based service provider that offers exceptional services to clients across diverse industries with our skilled personnel and robust infrastructure.
Our Digital Content Managers use their elevated understanding of healthcare and pharmaceutical industry requirements, to handle assets and metadata correctly in an FDA regulated industry.
More at risetime.com
Generis is a UK-headquartered developer of world-class data, content and business process management for regulated industries globally. 60% of the top 20 life sciences companies rely on Generis' flagship CARA™ Life Sciences Platform, including AbbVie, UCB, Biogen, Reckitt, Bristol Myers Squibb, Bayer, Pfizer, and Merck KGaA. Today Generis serves more than 750,000 users worldwide, across use cases ranging from RIM, Regulatory / R&D and Safety use cases to Clinical, Non-clinical, Quality GxP, CMC, Pharmacovigilance, Medical Information / Medical Affairs applications and more. More at generiscorp.com.
Karolina Rogowska, Marketing Manager